
When you buy through links on our articles, Future and its syndication partners may earn a commission.
The launch of a new batch of SpaceX Starlink satellites lit up the predawn sky in southern California today (Dec. 10) as the company marked its 160th flight of a Falcon 9 rocket this year.
Lifting off at 6:40 a.m. EST (1140 GMT or 3:40 a.m. PST local time) Wednesday from Vandenberg Space Force Base's Launch Complex 4 East (SLC-4E), the 27 broadband internet satellites (Group 15-11) were deployed into low Earth orbit just over an hour into the flight.
"Deployment of 27 Starlink satellites confirmed," SpaceX officials posted to social media.
Previous Booster 1082 missions
USSF-62 | OneWeb Launch 20 | NROL-145 | 14 Starlink missions
The first stage of the Falcon 9 rocket completed its 18th flight, landing back on the autonomous droneship "Of Course I Still Love You" positioned in the Pacific Ocean.
The Starlink megaconstellation now numbers more than 9,000 operational satellites, including the more than 3,000 launched just this year. The network provides access to the internet to areas around the world where there was no or sparse coverage, as well as enables WiFi access on commercial airliners and cell-to-satellite service on select providers.
Wednesday's launch was SpaceX's 165th overall launch of 2025 (including Starship test flights) and the 605th mission in the company's history.
LATEST POSTS
Kona SUV: The Courageous Minimized That is Catching Hearts Around the world
‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
Must-See Attractions in France
Vote In favor of Your Favored Web-based Book Retailor
Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
Telecommute Arrangement: What's Pivotal for Your Efficiency?
Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas













